Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Bellicum Pharmaceuticals Inc (BLCM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bellicum Pharmaceuticals Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.460 -0.090    -5.81%
20/05 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US0794814048 
CUSIP:  079481404
  • Volume: 17,908
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.420 - 1.550
Bellicum Pharmaceuticals Inc 1.460 -0.090 -5.81%
Oncology players in the red on Celgene deal
Oncology players in the red on Celgene deal By Seeking Alpha - Jan 03, 2019

A wide range of oncology companies are under modest pressure after deal-hungry Bristol-Myers Squibb (NYSE:BMY) announced its $74B bid for Celgene (NASDAQ:CELG), thereby removing a top candidate from...

Bellicum Pharmaceuticals appoints Atabak Mokari as CFO
Bellicum Pharmaceuticals appoints Atabak Mokari as CFO By Seeking Alpha - Dec 13, 2018

Bellicum Pharmaceuticals (NASDAQ:BLCM) appoints Atabak Mokari as Chief Financial Officer (CFO), effective December 19. Mr. Mokari joins Bellicum from IRIDEX Corporation, where he served as CFO and VP...

ARCO, SRT, CIG and AM among after hour movers
ARCO, SRT, CIG and AM among after hour movers By Seeking Alpha - Nov 30, 2018

Top Gainers: OTCPK:VIEMF +31.34%. ARCO +6.55%. SRT +5.77%. AAC +5.58%. BSM +4.18%. Top Losers: CIG -4.95%. BLCM -4.73%. AM -4.01%. HOME 4%. HTHT -3.99%. Now read: Antero Midstream Partners 2018 Q3 -...

Key events next week - healthcare
Key events next week - healthcare By Seeking Alpha - Nov 23, 2018

Noteworthy events during the week of November 25 - December 1 for healthcare investors. MONDAY (11/26): FDA action date for Loxo Oncology's (NASDAQ:LOXO) larotrectinib in NTRK fusion-positive solid...

Bellicum finance chief to bid adieu
Bellicum finance chief to bid adieu By Seeking Alpha - Jul 16, 2018

Bellicum Pharmaceuticals (NASDAQ:BLCM) CFO Alan Musso will depart effective August 31. VP of Finance and Controller Rosemary Williams will serve as interim principal accounting officer. A search for a...

Midday Gainers / Losers (04/17/2018)
Midday Gainers / Losers (04/17/2018) By Seeking Alpha - Apr 17, 2018

Gainers: CNET +42%. WMLP +21%. CIFS +21%. CLXT +20%. IIN +19%. NVLN +15%. IFON +15%. DPW +14%. CHEK +14%. GTHX +14%.Losers: APLS -14%. OTCQX:NVMM -11%. BLCM -10%. SEAC -10%. TMQ -9%. GPRO -8%. CUR...

Premarket Losers as of 9:05 am (4/17/2018)
Premarket Losers as of 9:05 am (4/17/2018) By Seeking Alpha - Apr 17, 2018

LADR -9%.BLCM -7% on announcing public offering of common stock.AVXL -6% on announcing its plans to initiate a Phase 2 trial evaluating ANAVEX 2-73 in patients with PDD. Now read: Blue Chip Yields...

After Hours Gainers / Losers (04/11/2018)
After Hours Gainers / Losers (04/11/2018) By Seeking Alpha - Apr 11, 2018

Top gainers: QNST +20.9%. BLCM +15.3%. ALRN +4.3%. VEON +2.1%. FTI +1.4%.Top losers: BBBY -13.2%. AXTI -10.1%. AGX -4.4%. DQ -4.3%. GFA -3.3%. Now read: Upcoming Conversation With An Expert:...

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BLCM Comments

Write your thoughts about Bellicum Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Marinero Mohamed Nabawy
Marinero Mohamed Nabawy Feb 11, 2021 10:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
With today volume can this reach 20$ ?
Ektoras Stylianou
Ektoras Stylianou Jan 29, 2021 10:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
its on !⚡⚡
Massimo Dauria
Massimo Dauria Mar 02, 2020 3:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the worst stock ever
PAPPAERT ANDRE
PAPPAERT ANDRE Jul 25, 2019 6:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Achteruitgang van het aandeel,  in de naverkoop nochtans zien de . Kandelaarpatronen er zeer positief uit, of is het om eerst de prijs van het aandeel naar beneden te drukken alvorens men weder koopt?
Tarahumara Investor
Tarahumara Investor Apr 11, 2019 5:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This the worst low volume bio stock to own because it trades regardless of news, usually opposite of good news, lost 70% value since ASH meeting despite no negative news, hardly gained 20% while ZIOP nearly tripled without news.
Tim Caron
Tim Caron Jan 31, 2018 10:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What are people thinking about the return of this stock?
Episcopolian OptionTrader
Episcopolian1 Sep 26, 2017 9:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$BLCM: Buy this stock before the big news!
Colin Patton
Colin Patton Jul 28, 2017 11:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I bought this stock on the recommendation of a paid investment adviser. Since I bought the stock it is down about 15%. I was told that the stock was set to explode after a meeting it had with top pharmaceutical companies a few weeks ago to discuss some phase 2 test results. Supposedly the stock was set to "explode" in price after this meeting. Since then I have head nothing and he stock price has slowly gone down. The excuse is that the stock is in an overbought position. If the results of the phase 2 tests wee so good why haven't I heard about hem in the news media? That is what is needed to drive this stock. Otherwise, let me know what the status is so that I can invest my money somewhere else.
Benjamin Wilbur
Benjamin Wilbur Jul 28, 2017 11:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is going to explode. Hold your shares
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email